Skip to content

Clinical Study on the Efficacy and Safety of Flexible Ureteroscopic Lithotripsy via the Urethra

Clinical Study on the Efficacy and Safety of Flexible Ureteroscopic Lithotripsy via the Urethra

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124014
Enrollment
Unknown
Registered
2026-05-06
Start date
2023-03-09
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Urinary Tract Calculi

Interventions

Experimental Group:Renal Pelvis Irrigation with Diluted Povidone-Iodine to Observe Postoperative Infection and Bleeding Conditions
Control Group:Renal pelvis irrigation with normal saline, observing postoperative infection and bleeding conditions.

Sponsors

Changshu No.2 People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18–80 years. 2.Undergo FRUS surgery, with intraoperative assessment by the primary surgeon that surgical field visibility is compromised due to mucosal bleeding from the renal pelvis, calyces, or upper ureter. 3.Normal preoperative coagulation function (PT 10–13 s, APTT 25–27 s). 4.Voluntarily participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Known allergy to povidone-iodine, iodine, or carbazochrome sodium sulfonate. 2.History of hyperthyroidism, thyroid nodules, or other thyroid diseases. 3.Severe cardiac, hepatic, or renal insufficiency (e.g., eGFR < 30 mL/min/1.73 m²). 4.Presence of uncontrolled urinary tract infection or systemic infection before surgery. 5.Pregnant or breastfeeding women. 6.Active arterial bleeding (spurting) identified during surgery.

Design outcomes

Primary

MeasureTime frame
Primary Stone Removal Proportion;

Secondary

MeasureTime frame
Bleeding Incidence;Infection Incidence;

Countries

China

Contacts

Public ContactFu Zhenyu

Changshu No.2 People’s Hospital

fuzhenyu592@aliyun.com+86 158 9556 9960

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026